The UK regulator MHRA announced on 26 June that it would again permit recruitment to the COPCOV COVID-19 prevention clinical trial. The MHRA decision came 5 weeks after it reacted immediately to the now-discredited paper published in The Lancet suggesting harms with hydroxychloroquine, and paused recruitment of UK participants. But The Lancet paper was based […]
A new type of aerosol shield designed by motor racing engineers to improve the treatment of COVID-19 patients and safety of clinical staff has been approved for use at a leading NHS trust. Staff at Oxford University Hospitals (OUH) NHS Foundation Trust say the new ‘Oxford Box’ could mark a significant breakthrough in the treatment of […]
Participants in South Africa’s first clinical trial for a vaccine against COVID-19 are to be vaccinated this week. Dr. Shabir Madhi, Professor of Vaccinology at Wits University and Director of the South Africa Medical Research Council (SAMRC) Vaccines and Infectious Diseases Analytics Research Unit (VIDA) who leads the South African Ox1Cov-19 Vaccine VIDA-Trial The first […]
The Duke of Cambridge visits the University of Oxford’s Oxford Vaccine Centre, to learn more about their work to establish a viable vaccine against COVID-19. Oxford researchers have developed a vaccine in order to begin protecting people against the coronavirus as soon as possible and clinical trials are now underway to establish whether the vaccine […]
Testing for coronavirus infection could become quicker, more convenient and more accurate, following the launch of a multicentre national programme of research that will evaluate how new diagnostic tests perform in hospitals, general practices and care homes. The COVID-19 National DiagnOstic Research and Evaluation Platform (CONDOR) will create a single national route for evaluating new […]
Oxford University has received a landmark £80 million donation from the Reuben Foundation that will transform Oxford’s newest college and establish a major new scholarship programme for graduate and undergraduate students. © Alison Stibbe The University last year established its 39th college – the first for 30 years – as a new base for graduate […]
As part of the UK NIHR multi-arm, multi-stage CATALYST Trial, researchers at the University of Oxford will investigate whether administering the anti-inflammatory drug infliximab to patients with COVID-19 can prevent progression to respiratory failure or death. In some patients, COVID-19 can progress to severe respiratory failure requiring admission to an intensive care unit and mechanical […]
A team of radiologists and radiographers at Oxford University Hospitals and University of Oxford’s Department of Oncology has secured a grant to customise a teaching platform to educate frontline NHS staff to diagnose COVID-19 using chest X-rays and CT scans. Dr Sarim Ather, a Specialist Registrar in Clinical Radiology, has been working alongside Professor Fergus Gleeson (Department […]
On 2 June, the Brazilian Health Regulatory Agency (ANVISA) approved the inclusion of Brazil in the clinical trials conducted by Oxford University and supported by AstraZeneca, considering 2,000 volunteers to be tested in the country. On April 30, the University of Oxford and AstraZeneca announced an agreement for the global development and distribution of the […]
The University of Oxford in partnership with AstraZeneca has taken the next steps in its commitment to broad and equitable global access to Oxford’s COVID-19 vaccine, following landmark agreements with the Coalition for Epidemic Preparedness Innovations (CEPI), Gavi the Vaccine Alliance, and the Serum Institute of India (SII). AstraZeneca has reached a $750m agreement with […]